Grifols Class A/€GRF
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Grifols Class A
Grifols SA, operating under the ticker GRF, is a biopharmaceutical company specialized in the production of plasma-derived medicines. Founded in 1940 and headquartered in Barcelona, Spain, Grifols is engaged in the diagnosis, prevention, and treatment of a variety of diseases, with a strong focus on immunology, hematology, and intensive care sectors. The company operates globally, leveraging advanced technologies and rigorous quality processes to provide essential medical products.
Ticker
€GRF
Sector
Primary listing
BME
Employees
25,258
Headquarters
Website
Grifols Class A Metrics
BasicAdvanced
€5.9bn
15.36
€0.66
1.18
€0.19
1.86%
Price and volume
Market cap
€5.9bn
Beta
1.18
52-week high
€13.26
52-week low
€8.46
Average daily volume
1.9m
Dividend rate
€0.19
Financial strength
Current ratio
2.373
Quick ratio
0.697
Long term debt to equity
110.376
Total debt to equity
117.243
Dividend payout ratio (TTM)
28.32%
Interest coverage (TTM)
2.24%
Profitability
EBITDA (TTM)
1,559.231
Gross margin (TTM)
37.40%
Net profit margin (TTM)
6.09%
Operating margin (TTM)
17.60%
Effective tax rate (TTM)
19.16%
Revenue per employee (TTM)
€290,000
Management effectiveness
Return on assets (TTM)
4.10%
Return on equity (TTM)
6.93%
Valuation
Price to earnings (TTM)
15.362
Price to revenue (TTM)
0.934
Price to book
1.07
Price to tangible book (TTM)
-1.39
Price to free cash flow (TTM)
10.802
Free cash flow yield (TTM)
9.26%
Free cash flow per share (TTM)
0.939
Dividend yield (TTM)
1.86%
Growth
Revenue change (TTM)
-0.33%
Earnings per share change (TTM)
46.08%
3-year revenue growth (CAGR)
4.63%
10-year revenue growth (CAGR)
6.41%
3-year earnings per share growth (CAGR)
329.35%
10-year earnings per share growth (CAGR)
-1.77%
What the Analysts think about Grifols Class A
Analyst ratings (Buy, Hold, Sell) for Grifols Class A stock.
Grifols Class A Financial Performance
Revenues and expenses
Grifols Class A Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.